Aimovig – pharmaceutical daily

June 1, 2018 Off

Novartis’s first targeted migraine prevention therapy to patients in Europe

Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval for Novartis’s Aimovig…

May 18, 2018 Off

By Dino Mustafić

The US Food and Drug Administration (FDA) has approved Novartis’s and Amgen’s Aimovig (erenumab) for the preventive treatment of migraine in…

January 23, 2018 Off

By Dino Mustafić

Amgen’s Phase 3b study called Liberty, in co-development with Novartis, aimed to test Aimovig for treating migraine, has met it’s…